General Information of Drug (ID: DMULZ4W)

Drug Name
CHR-2797 Drug Info
Synonyms Tosedostat; Tosedostat, CHR2797, CHR-2797
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 2 [1]
Myelodysplastic syndrome 2A37 Phase 2 [2]
Inflammation 1A00-CA43.1 Terminated [3]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
15547703
ChEBI ID
CHEBI:95044
CAS Number
CAS 238750-77-1
TTD Drug ID
DMULZ4W

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Aminopeptidase (AMP) TTWLEZV NOUNIPROTAC Inhibitor [2]
Puromycin-sensitive aminopeptidase (NPEPPS) TT371QC PSA_HUMAN Inhibitor [4]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Puromycin-sensitive aminopeptidase (NPEPPS) DTT NPEPPS 6.142 6.779 6.6 6.838
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Acute myeloid leukaemia
ICD Disease Classification 2A60
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Puromycin-sensitive aminopeptidase (NPEPPS) DTT NPEPPS 8.88E-01 7.78E-03 1.30E-02
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022187)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014340)
4 CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells. Cancer Res. 2008 Aug 15;68(16):6669-79.